Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Ankylosing Spondylitis Clinical Trials
Ankylosing Spondylitis clinical trials are recruiting across 200 cities. Here are the cities with the most active studies:
Ankylosing Spondylitis Trial Phases
80 research organizations are sponsoring ankylosing spondylitis trials.
About Ankylosing Spondylitis
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
Clinical trials are advancing new treatments for ankylosing spondylitis. Currently, 100 studies are recruiting a combined 22,974,676 participants across the United States. Research is being conducted by 80 organizations including American Academy of Ophthalmology, Helix, Inc, University of Southern California and 77 others.
2026 Ankylosing Spondylitis Research Landscape
As of July 2026, the ankylosing spondylitis clinical trial landscape includes 100 actively recruiting studies across 200 cities in the United States. These studies are collectively seeking 22,974,676 participants, with an average enrollment target of 229,747 per study.
The research spans multiple phases of development: 17 studies are in PHASE3, 11 studies are in NA, 1 study is in PHASE4, 1 study is in PHASE2. The presence of Phase 3 trials indicates that some ankylosing spondylitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 80 different organizations, including American Academy of Ophthalmology, Helix, Inc, University of Southern California, Scott C. Woller, MD, Anova Enterprises, Inc, and 75 others. The large number of sponsors reflects significant research interest and investment in ankylosing spondylitis treatment advancement.
Geographically, ankylosing spondylitis trials are most concentrated in Los Angeles, California (16 trials); Bethesda, Maryland (16 trials); Phoenix, Arizona (12 trials); Tucson, Arizona (11 trials); Chicago, Illinois (11 trials) and 7 other cities.
Featured Ankylosing Spondylitis Studies
Highlighted recruiting studies for ankylosing spondylitis, selected by enrollment size and research scope.
IRIS Registry: Intelligent Research in Sight Registry
The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excell...
Helix Research Network
The Helix Research Network ("HRN") is a network of academic, public, and/or private healthcare organizations that are committed to advancing medical research and improving human health through large-scale genomics research and acceleration of the integration of genomic and other omics data into clinical care.
Alzheimer Prevention Trials (APT) Webstudy
The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.
Frequently Asked Questions About Ankylosing Spondylitis Clinical Trials
Are there ankylosing spondylitis clinical trials near me?
Yes, there are 100 ankylosing spondylitis clinical trials currently recruiting across 200+ cities in the United States, including Los Angeles, California; Bethesda, Maryland; Phoenix, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a ankylosing spondylitis clinical trial?
To join a ankylosing spondylitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are ankylosing spondylitis clinical trials free?
Yes, participation in ankylosing spondylitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of ankylosing spondylitis treatments are being studied?
Current ankylosing spondylitis clinical trials are testing a range of approaches across PHASE3 (17 studies), NA (11 studies), PHASE4 (1 study), PHASE2 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 80 research organizations.
Is it safe to participate in ankylosing spondylitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov